Immutep Ltd Files Routine 6-K Report
Ticker: PRRUF · Form: 6-K · Filed: Oct 30, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Oct 30, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, foreign-private-issuer
TL;DR
IMMUTEP files routine 6-K, no major news.
AI Summary
Immutep Limited filed a Form 6-K on October 29, 2024, reporting its status as a foreign private issuer. The company, formerly known as Prima BioMed Ltd, is incorporated in Australia and has its principal executive offices in Sydney. This filing does not appear to contain specific financial or operational updates beyond its routine reporting requirements.
Why It Matters
This filing is a standard procedural document for foreign private issuers, indicating Immutep is meeting its SEC reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new material information.
Key Players & Entities
- IMMUTEP Limited (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- 001-35428 (dollar_amount) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. It is used to furnish information which the registrant may be required to make public pursuant to the laws of its home country, or which it may be required to publish or file with any stock exchange on which its securities are traded.
When was this Form 6-K filed?
This Form 6-K was filed on October 29, 2024.
What is Immutep Limited's former name?
Immutep Limited's former name was Prima BioMed Ltd.
Where are Immutep Limited's principal executive offices located?
Immutep Limited's principal executive offices are located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Does Immutep Limited file annual reports under Form 20-F or 40-F?
Immutep Limited indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 255 words · 1 min read · ~1 pages · Grade level 17 · Accepted 2024-10-29 19:36:49
Filing Documents
- d878340d6k.htm (6-K) — 9KB
- d878340dex991.htm (EX-99.1) — 115KB
- g878340g01g01.jpg (GRAPHIC) — 15KB
- 0001193125-24-246722.txt ( ) — 146KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: October 29, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer